ATE550029T1 - Mittel zur prävention oder heilung von hepatopathie - Google Patents

Mittel zur prävention oder heilung von hepatopathie

Info

Publication number: ATE550029T1
Authority: AT; Austria
Prior art keywords: amino acid; hepatopathy; preventive; hepatic; therapeutic agent
Prior art date: 2003-04-30

Application number

AT04730725T

Other languages

English (en)

Inventor

Kenji Kangawa

Hiroshi Hosoda

Original Assignee

Kenji Kangawa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-30

Filing date

2004-04-30

Publication date

2012-04-15

2004-04-30 Application filed by Kenji Kangawa filed Critical Kenji Kangawa

2012-04-15 Application granted granted Critical

2012-04-15 Publication of ATE550029T1 publication Critical patent/ATE550029T1/de

Links

208000019423 liver disease Diseases 0.000 title abstract 5
125000003275 alpha amino acid group Chemical group 0.000 abstract 4
239000003814 drug Substances 0.000 abstract 4
230000003449 preventive effect Effects 0.000 abstract 3
229940124597 therapeutic agent Drugs 0.000 abstract 3
125000000539 amino acid group Chemical group 0.000 abstract 2
BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 abstract 1
102000000393 Ghrelin Receptors Human genes 0.000 abstract 1
108010016122 Ghrelin Receptors Proteins 0.000 abstract 1
238000012752 Hepatectomy Methods 0.000 abstract 1
208000000857 Hepatic Insufficiency Diseases 0.000 abstract 1
206010019663 Hepatic failure Diseases 0.000 abstract 1
150000001413 amino acids Chemical class 0.000 abstract 1
229910001424 calcium ion Inorganic materials 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
208000019425 cirrhosis of liver Diseases 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000003028 elevating effect Effects 0.000 abstract 1
230000002440 hepatic effect Effects 0.000 abstract 1
208000006454 hepatitis Diseases 0.000 abstract 1
231100000283 hepatitis Toxicity 0.000 abstract 1
239000004615 ingredient Substances 0.000 abstract 1
230000003834 intracellular effect Effects 0.000 abstract 1
230000003908 liver function Effects 0.000 abstract 1
229920001184 polypeptide Polymers 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
230000001737 promoting effect Effects 0.000 abstract 1
238000011084 recovery Methods 0.000 abstract 1
230000008929 regeneration Effects 0.000 abstract 1
238000011069 regeneration method Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Endocrinology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Zoology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT04730725T 2003-04-30 2004-04-30 Mittel zur prävention oder heilung von hepatopathie ATE550029T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2003126088		2003-04-30
PCT/JP2004/006365 WO2004096260A1 (ja)	2003-04-30	2004-04-30	肝障害予防治療剤

Publications (1)

Publication Number	Publication Date
ATE550029T1 true ATE550029T1 (de)	2012-04-15

Family

ID=33410283

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04730725T ATE550029T1 (de)	2003-04-30	2004-04-30	Mittel zur prävention oder heilung von hepatopathie

Country Status (11)

Country	Link
US (1)	US10653637B2 (de)
EP (1)	EP1632244B1 (de)
JP (1)	JP4467518B2 (de)
KR (1)	KR20060015555A (de)
CN (1)	CN1780635B (de)
AT (1)	ATE550029T1 (de)
AU (1)	AU2004233705C1 (de)
BR (1)	BRPI0409877A (de)
CA (1)	CA2523576A1 (de)
ES (1)	ES2383685T3 (de)
WO (1)	WO2004096260A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1750745A1 (de) *	2004-05-11	2007-02-14	The United States of America, represented by the Secretary, Department of Health and Human Services	Verfahren zur hemmung der expression von proinflammatorischem cytokin unter verwendung von ghrelin
JP2008521840A (ja) *	2004-11-30	2008-06-26	ガストロテック・ファルマ・アクティーゼルスカブ	成長ホルモン分泌促進物質レセプター１ａリガンド
CU23592A1 (es) *	2006-02-28	2010-11-11	Ct Ingenieria Genetica Biotech	Método para prevenir y eliminar las fibrosis y otras formas de depósito patológico en los tejidos aplicando el péptido secretagogo ghrp-6
KR20120082906A (ko)	2009-09-30	2012-07-24	프레지던트 앤드 펠로우즈 오브 하바드 칼리지	자가포식현상-향상 유전자 생성물의 조절을 통한 자가포식현상의 조절 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5492891A (en) *	1991-09-05	1996-02-20	Novo Nordisk A/S	Method for treatment of patients with chronic liver disease
CN100506844C (zh) *	1999-07-23	2009-07-01	寒川贤治	新的肽
US20030096411A1 (en) *	1999-12-07	2003-05-22	George Michalopoulos	Novel long-term three-dimensional tissue culture system
AU2001228325A1 (en) *	2000-02-01	2001-08-14	Novo-Nordisk A/S	Use of compounds for the regulation of food intake
US20010020012A1 (en) *	2000-02-01	2001-09-06	Andersen Maibritt Bansholm	Use of compounds for the regulation of food intake
US6967237B2 (en)	2000-05-30	2005-11-22	Merck & Co., Inc.	Ghrelin analogs
JP4493913B2 (ja) *	2001-01-31	2010-06-30	中外製薬株式会社	低栄養症状疾患治療剤

2004
- 2004-04-30 ES ES04730725T patent/ES2383685T3/es not_active Expired - Lifetime
- 2004-04-30 CN CN2004800116229A patent/CN1780635B/zh not_active Expired - Fee Related
- 2004-04-30 CA CA002523576A patent/CA2523576A1/en not_active Abandoned
- 2004-04-30 WO PCT/JP2004/006365 patent/WO2004096260A1/ja not_active Ceased
- 2004-04-30 EP EP04730725A patent/EP1632244B1/de not_active Expired - Lifetime
- 2004-04-30 AU AU2004233705A patent/AU2004233705C1/en not_active Ceased
- 2004-04-30 BR BRPI0409877-3A patent/BRPI0409877A/pt not_active Application Discontinuation
- 2004-04-30 JP JP2005505958A patent/JP4467518B2/ja not_active Expired - Lifetime
- 2004-04-30 AT AT04730725T patent/ATE550029T1/de active
- 2004-04-30 US US10/554,875 patent/US10653637B2/en active Active
- 2004-04-30 KR KR1020057020591A patent/KR20060015555A/ko not_active Abandoned

Also Published As

Publication number	Publication date
CA2523576A1 (en)	2004-11-11
KR20060015555A (ko)	2006-02-17
EP1632244B1 (de)	2012-03-21
AU2004233705A1 (en)	2004-11-11
WO2004096260A1 (ja)	2004-11-11
US20070219114A1 (en)	2007-09-20
CN1780635B (zh)	2011-04-13
ES2383685T3 (es)	2012-06-25
AU2004233705B2 (en)	2009-09-17
EP1632244A4 (de)	2009-11-11
JP4467518B2 (ja)	2010-05-26
AU2004233705C1 (en)	2010-04-01
JPWO2004096260A1 (ja)	2006-07-13
EP1632244A1 (de)	2006-03-08
US10653637B2 (en)	2020-05-19
CN1780635A (zh)	2006-05-31
BRPI0409877A (pt)	2006-05-16

Similar Documents

Publication	Publication Date	Title
JP2004000251A5 (de)	2007-09-06
HUP0004560A2 (hu)	2001-04-28	Törést gyógyító PTHrP analógok
ATE540973T1 (de)	2012-01-15	Zusammensetzungen und verfahren zur verwendung von mgd-cdf zur krankheitsbehandlung
EA199901025A1 (ru)	2000-06-26	Пептидные аналоги паратиреоидного гормона
JP2005527470A5 (de)	2006-10-05
ATE366813T1 (de)	2007-08-15	Neue peptide
RU2000109305A (ru)	2002-02-10	ЗАЖИВЛЕНИЕ ПЕРЕЛОМОВ С ПОМОЩЬЮ АНАЛОГОВ ПЕПТИДА, ПОДОБНОГО ПАРАТИРЕОИДНОМУ ГОРМОНУ (РТНrР)
JP2006506942A5 (de)	2006-04-13
CY1109631T1 (el)	2014-08-13	Χρησιμοποιηση πεπτιδιων, τα οποια εχουν παραχθει απο την αα- ή ββ-αλυσιδα του ανθρωπινου ινωδογονου, για τη θεραπεια σοκ
DK384084A (da)	1985-02-11	Vaeksthormonfrigoerende peptider samt fremgangsmaade til behandling af pattedyr hermed
ATE425763T1 (de)	2009-04-15	Verwendung von zusammensetzungen mit der biologischen aktivitat der vasoaktiven intestinalen peptide zur behandlung von sarcoidose
JP2012524775A (ja)	2012-10-18	副甲状腺ホルモン（ｐｔｈ）受容体アゴニストとしての短鎖ペプチド
SK12097A3 (en)	1997-08-06	Parathormone derivatives and parathormone correlated peptide, preparation method thereof and pharmaceutical composition containing them
EP1632244A4 (de)	2009-11-11	Mittel zur prävention oder heilung von hepatopathie
JP2006507229A5 (de)	2006-08-17
WO2013113916A2 (en)	2013-08-08	Ghrelin analogues
ATE362939T1 (de)	2007-06-15	Dimere von thrombinpeptidderivaten
RU2002135669A (ru)	2004-07-20	Олигопептиды
DK1091774T3 (da)	2003-02-24	Knoglecement med antimikrobielle peptider
CA2413195A1 (en)	2002-12-17	Ligand to gpr8 and dna thereof
CN1060178C (zh)	2001-01-03	新的结构改性的活性肠肽衍生物、其药物组合物及其治疗男性阳痿的应用
RU2003102629A (ru)	2004-05-10	Фармацевтический компонент на основе паратиреоидного гормона человека и содержащая его фармацевтическая композиция для интраназального применения
ITMI912582A1 (it)	1993-03-27	Mutanti dell'ormone della crescita umano e loro impiego
ATE291033T1 (de)	2005-04-15	Therapeutische peptide
JP2004535397A5 (de)	2006-01-05